| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;46:1069.)
© 2005 American Heart Association, Inc.
Brief Reviews |
From the Department of Pharmacology (A.H.J.D.), Erasmus MC, Rotterdam; and the Department of Internal Medicine (J.D.), UMCN St. Radboud, Nijmegen, The Netherlands
Correspondence to A.H.J. Danser, Department of Pharmacology, Room EE1418b, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. E-mail a.danser@erasmusmc.nl
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Renin has also been called active renin to underline that an enzymatically inactive form of renin exists. In 1971, Lumbers found that amniotic fluid, left at low pH in the cold, acquired renin activity.2 Later, Skinner described a similar phenomenon in plasma.3 Acidification was not strictly necessary for this increase in Ang I-generating activity, because incubation at low temperature also increased renin activity, albeit to only 15% of activity after acidification. Soon it was postulated that this inactive, but activatable "big" renin (its molecular weight was 5 kDa higher than that of renin) was the biosynthetic precursor of renin. Hence, it was named prorenin. Only with the cloning of the renin gene in 1984 was prorenin definitively proved to be the precursor of renin.4 For reasons that are unknown, prorenin circulates in human plasma in excess to renin, sometimes at concentrations that are 100-times higher.5 Prorenin has also been demonstrated in plasma of cat, dog, cattle, pig, horse, sheep, rabbit, rat, and mouse.
A 43-amino acid N-terminal propeptide explains the absence of enzymatic activity of prorenin. This propeptide covers the enzymatic cleft and obstructs access of angiotensinogen to
This article has been cited by other articles:
![]() |
A.H. J. Danser Does Prorenin Exert Angiotensin-Independent Effects In Vivo? Hypertension, December 1, 2009; 54(6): 1218 - 1220. [Full Text] [PDF] |
||||
![]() |
F. Persson, P. Rossing, H. Reinhard, T. Juhl, C. D.A. Stehouwer, C. Schalkwijk, A.H. J. Danser, F. Boomsma, E. Frandsen, and H.-H. Parving Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria Diabetes Care, October 1, 2009; 32(10): 1873 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.H. J. Danser (Pro)renin Receptor and Vacuolar H+-ATPase Hypertension, August 1, 2009; 54(2): 219 - 221. [Full Text] [PDF] |
||||
![]() |
P. S Sever, A. H Gradman, and M. Azizi Managing cardiovascular and renal risk: the potential of direct renin inhibition Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 65 - 76. [Abstract] [PDF] |
||||
![]() |
H.-H. Parving, B. M. Brenner, John. J. V. McMurray, D. de Zeeuw, S. M. Haffner, S. D. Solomon, N. Chaturvedi, M. Ghadanfar, N. Weissbach, Z. Xiang, et al. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1663 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Campbell, J. Nussberger, M. Stowasser, A.H. J. Danser, A. Morganti, E. Frandsen, and J. Menard Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement Clin. Chem., May 1, 2009; 55(5): 867 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi, I. Toma, A. Sipos, and S. L. Vargas Multiphoton Imaging of Renal Regulatory Mechanisms Physiology, April 1, 2009; 24(2): 88 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klotz, D. Burkhoff, I. M. Garrelds, F. Boomsma, and A.H.J. Danser The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur. Heart J., April 1, 2009; 30(7): 805 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krop, I. M. Garrelds, R. J.A. de Bruin, J. M.G. van Gool, N. D.L. Fisher, N. K. Hollenberg, and A.H. Jan Danser Aliskiren Accumulates in Renin Secretory Granules and Binds Plasma Prorenin Hypertension, December 1, 2008; 52(6): 1076 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peti-Peterdi, J. J. Kang, and I. Toma Activation of the renal renin-angiotensin system in diabetes--new concepts Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3047 - 3049. [Full Text] [PDF] |
||||
![]() |
J. Zhang, N. A. Noble, W. A. Border, R. T. Owens, and Y. Huang Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E810 - E819. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W Batenburg and A. J. Danser Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 181 - 184. [PDF] |
||||
![]() |
J. Nussberger, A. Stanton, N. D.L. Fisher, N. K. Hollenberg, and A.H. Jan Danser Response to It Is the Plasma Renin Activity Level That Counts, not Stoichiometry Hypertension, August 1, 2008; 52(2): e21 - e21. [Full Text] [PDF] |
||||
![]() |
N. D.L. Fisher, A.H. Jan Danser, J. Nussberger, W. P. Dole, and N. K. Hollenberg Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans Circulation, June 24, 2008; 117(25): 3199 - 3205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kang, I. Toma, A. Sipos, E. J. Meer, S. L. Vargas, and J. Peti-Peterdi The Collecting Duct Is the Major Source of Prorenin in Diabetes Hypertension, June 1, 2008; 51(6): 1597 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Siragy and J. Huang Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity Exp Physiol, May 1, 2008; 93(5): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nguyen and A. H. J. Danser Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents Exp Physiol, May 1, 2008; 93(5): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Campbell Critical Review of Prorenin and (Pro)renin Receptor Research Hypertension, May 1, 2008; 51(5): 1259 - 1264. [Full Text] [PDF] |
||||
![]() |
A. H. J. Danser, A. Charney, D. L. Feldman, J. Nussberger, N. Fisher, and N. Hollenberg The Renin Rise With Aliskiren: It's Simply Stoichiometry Hypertension, April 1, 2008; 51(4): e27 - e28. [Full Text] [PDF] |
||||
![]() |
A. J. Danser The rise in renin following renin inhibition: an assay-artefact? Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1_suppl): S12 - S12. [PDF] |
||||
![]() |
A. H. Gradman and R. Kad Renin inhibition in hypertension. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 519 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Campbell Interpretation of Plasma Renin Concentration in Patients Receiving Aliskiren Therapy Hypertension, January 1, 2008; 51(1): 15 - 18. [Full Text] [PDF] |
||||
![]() |
F. Schweda, U. Friis, C. Wagner, O. Skott, and A. Kurtz Renin Release Physiology, October 1, 2007; 22(5): 310 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Brown Renin: friend or foe? Heart, September 1, 2007; 93(9): 1026 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft Renin and Its Putative Receptor Remain Enigmas J. Am. Soc. Nephrol., July 1, 2007; 18(7): 1989 - 1992. [Full Text] [PDF] |
||||
![]() |
F. Suzuki Nonproteolytic activation of prorenin by the (pro)renin receptor is blocked by decoy peptide Journal of Renin-Angiotensin-Aldosterone System, June 1, 2007; 8(2): 101 - 103. [PDF] |
||||
![]() |
J. L Zhuo and X. C Li Review: Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 23 - 33. [Abstract] [PDF] |
||||
![]() |
W. C. De Mello On the Pathophysiological Implications of an Intracellular Renin Receptor Circ. Res., December 8, 2006; 99(12): 1285 - 1286. [Full Text] [PDF] |
||||
![]() |
J. H. Schefe, M. Menk, J. Reinemund, K. Effertz, R. M. Hobbs, P. P. Pandolfi, P. Ruiz, T. Unger, and H. Funke-Kaiser A Novel Signal Transduction Cascade Involving Direct Physical Interaction of the Renin/Prorenin Receptor With the Transcription Factor Promyelocytic Zinc Finger Protein Circ. Res., December 8, 2006; 99(12): 1355 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krop, J. H.M. van Esch, and A.H. J. Danser Letter by Krop et al Regarding Article, "Role of p90 Ribosomal S6 Kinase-Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium" Circulation, October 24, 2006; 114(17): e556 - e556. [Full Text] [PDF] |
||||
![]() |
J. J. Saris, P. A.C. 't Hoen, I. M. Garrelds, D. H.W. Dekkers, J. T. den Dunnen, J. M.J. Lamers, and A.H. Jan Danser Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II Hypertension, October 1, 2006; 48(4): 564 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Muller and F. C. Luft Direct Renin Inhibition with Aliskiren in Hypertension and Target Organ Damage Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Danser and J. Deinum Spotlight on Renin: Renin, Prorenin and the Putative (Pro)renin Receptor Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 163 - 165. [PDF] |
||||
![]() |
G. Nguyen The (pro)renin receptor: biochemistry and potential significance Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 166 - 166. [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |